XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Warrants Issued in Connection with Convertible Notes [Member]
Common Stock [Member]
Warrants Issued in Connection with Convertible Notes [Member]
Additional Paid-in Capital [Member]
Warrants Issued in Connection with Convertible Notes [Member]
Retained Earnings [Member]
Warrants Issued in Connection with Convertible Notes [Member]
Warrants Issued for Consulting Fees [Member]
Common Stock [Member]
Warrants Issued for Consulting Fees [Member]
Additional Paid-in Capital [Member]
Warrants Issued for Consulting Fees [Member]
Retained Earnings [Member]
Warrants Issued for Consulting Fees [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2018                 13,977,868      
Balance at Dec. 31, 2018                 $ 1,398 $ 85,599,140 $ (75,134,316) $ 10,466,222
Share-based compensation                 509,528 509,528
Net loss                 (1,803,508) (1,803,508)
Issuance of common stock for directors’ fees (in shares)                 13,820      
Issuance of common stock for directors’ fees                 $ 1 16,505 16,506
Net loss                 (1,803,508) (1,803,508)
Balance (in shares) at Mar. 31, 2019                 13,991,688      
Balance at Mar. 31, 2019                 $ 1,399 86,125,173 (76,937,824) 9,188,748
Balance (in shares) at Dec. 31, 2018                 13,977,868      
Balance at Dec. 31, 2018                 $ 1,398 85,599,140 (75,134,316) 10,466,222
Net loss                       (3,229,251)
Net loss                       (3,229,251)
Balance (in shares) at Jun. 30, 2019                 14,295,923      
Balance at Jun. 30, 2019                 $ 1,429 86,436,197 (78,363,567) 8,074,059
Balance (in shares) at Mar. 31, 2019                 13,991,688      
Balance at Mar. 31, 2019                 $ 1,399 86,125,173 (76,937,824) 9,188,748
Issuance of common stock pursuant to securities purchase agreements (in shares)                 300,000      
Issuance of common stock pursuant to securities purchase agreements                 $ 30 449,970 450,000
Commitment fee adjustment                 (270,000) (270,000)
Share-based compensation                 125,549 125,549
Net loss                 (1,425,743) (1,425,743)
Issuance of common stock for directors’ fees (in shares)                 4,235      
Issuance of common stock for directors’ fees                 5,505 5,505
Net loss                 (1,425,743) (1,425,743)
Balance (in shares) at Jun. 30, 2019                 14,295,923      
Balance at Jun. 30, 2019                 $ 1,429 86,436,197 (78,363,567) 8,074,059
Balance (in shares) at Dec. 31, 2019                 14,411,432      
Balance at Dec. 31, 2019                 $ 1,441 87,436,402 (89,723,016) (2,285,173)
Issuance of common stock pursuant to securities purchase agreements (in shares)                 700,000      
Issuance of common stock pursuant to securities purchase agreements                 $ 70 1,032,430 1,032,500
Commitment fee adjustment                 (900,000) (900,000)
Beneficial conversion feature                 641,215 641,215
Issuance of common stock pursuant to warrant exercises (in shares)                 972,000      
Issuance of common stock pursuant to warrant exercises                 $ 97 1,457,903 1,458,000
Issuance of common stock for conversion of convertible note payable (in shares)                 2,307,690      
Issuance of common stock for conversion of convertible note payable                 $ 231 1,499,769 1,500,000
Deemed dividends related to down-round features                 112,686 (112,686)
Share-based compensation                 512,719 512,719
Net loss                 (3,370,282) (3,370,282)
Net loss                 (3,370,282) (3,370,282)
Balance (in shares) at Mar. 31, 2020                 18,391,122      
Balance at Mar. 31, 2020                 $ 1,839 91,793,124 (93,205,984) (1,411,021)
Balance (in shares) at Dec. 31, 2019                 14,411,432      
Balance at Dec. 31, 2019                 $ 1,441 87,436,402 (89,723,016) (2,285,173)
Net loss                       (4,942,991)
Net loss                       (4,942,991)
Balance (in shares) at Jun. 30, 2020                 22,181,315      
Balance at Jun. 30, 2020                 $ 2,218 95,558,928 (94,778,693) 782,453
Balance (in shares) at Mar. 31, 2020                 18,391,122      
Balance at Mar. 31, 2020                 $ 1,839 91,793,124 (93,205,984) (1,411,021)
Issuance of common stock pursuant to securities purchase agreements (in shares)                 251,518      
Issuance of common stock pursuant to securities purchase agreements                 $ 25 145,308 145,333
Issuance of common stock for conversion of convertible note payable (in shares)                 3,521,535      
Issuance of common stock for conversion of convertible note payable                 $ 352 2,288,648 2,289,000
Share-based compensation                 33,177 33,177
Net loss                 (1,572,709) (1,572,709)
Issuance of common stock for directors’ fees (in shares)                 17,140      
Issuance of common stock for directors’ fees                 $ 2 15,005 15,007
Warrants issued $ 1,388,339 $ 1,388,339 $ 94,655 $ 94,655        
Warrants issued $ 1,388,339 $ 1,388,339 $ 94,655 $ 94,655        
Legal and commitment fees                 (199,328) (199,328)
Net loss                 (1,572,709) (1,572,709)
Balance (in shares) at Jun. 30, 2020                 22,181,315      
Balance at Jun. 30, 2020                 $ 2,218 $ 95,558,928 $ (94,778,693) $ 782,453